Inovio’s Kim on Using Immune System to Cure Cancer (Audio)

Dr. J. Joseph Kim, president and chief executive officer at Inovio Pharmaceuticals Inc. (INO), discusses the company’s attempt to develop a drug that trains the immune system to fight cancer. Kim talks with Bloomberg’s Pimm Fox and Carol Massar on Bloomberg Radio’s "Taking Stock" on February 12th.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.